Use of fetal magnetic resonance imaging in patients electing termination of pregnancy by dilation and evacuation

American Journal of Obstetrics and Gynecology

Volumn 189, Issue 4, 2003, Pages 990-993

  Sharma, Geeta ^a   Heier, Linda ^a   Kalish, Robin B ^a   Troiano, Robert ^a   Chasen, Stephen T ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Central nervous system; Fetal anomaly; Magnetic resonance imaging; Ultrasound examination

Indexed keywords

ARTICLE; AUTOPSY; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN MALFORMATION; BRAIN TERATOMA; BRAIN TUMOR; CEREBELLUM HYPOPLASIA; CLINICAL ARTICLE; DEVELOPMENTAL DISORDER; DILATATION AND EVACUATION; FEMALE; FETUS; FETUS ECHOGRAPHY; FETUS MALFORMATION; GENETIC DISORDER; HOLOPROSENCEPHALY; HUMAN; HUMAN TISSUE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREGNANCY TERMINATION; PRIORITY JOURNAL; UTERINE CERVIX DILATATION;

EID: 0242677617     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0002-9378(03)00712-9     Document Type: Article

References (13)

1. Levine D, Barnes PD, Madsen JR, Abbott J, Mehta T, Edelman RR. Central nervous system abnormalities assessed with prenatal magnetic resonance imaging. Obstet Gynecol 1999;94:1011-9.
2. Simon EM, Goldstein RB, Coakley FV, Filly RA, Broderick KC, Musci TJ, et al. Fast MR imaging of fetal CNS anomalies in utero. Am J Neuroradiol 2000;21:1688-98.
3. Guo WY, Chang CY, Ho DMT, Wong TT, Sheu MH, Cheng HC, et al. A comparative MR and pathological study on fetal CNS disorders. Child Nerv Syst 2001;17:512-8.
4. Wagenvoort AM, Bekker MN, Go AT, Vandenbussche FP, Van Buchem MA, Valk J, et al. Ultrafast scan magnetic resonance in prenatal diagnosis. Fetal Diagn Ther 2000;15:364-72.
5. Hubbard AM, States LJ. Fetal magnetic resonance imaging. Top Magn Reson Imaging 2001;12:93-103.
6. Baker PN, Johnson IR, Harvey PR, Gowland PA, Mansfield P. A three-year follow up of children imaged in utero with echo-planar magnetic resonance. Am J Obstet Gynecol 1994;170:32-3.
7. Saari-Kemppainen A, Karjalainen O, Ylöstalo P, Heinonen OP. Ultrasound screening and perinatal mortality: controlled trial of systematic one-stage screening in pregnancy: the Helsinki Ultrasound Trial. Lancet 1990;336:387-91.
8. Julian-Reynier C, Philip N, Scheiner C, Aurran Y, Chabal F, Maron A, et al. Impact of prenatal diagnosis by ultrasound on the prevalence of congenital anomalies at birth in southern France. J Epidemiol Community Health 1994;48:290-6.
9. Autry AM, Hayes EC, Jacobson GE, Kirby RS. A comparison of medical induction and dilation and evacuation for second-trimester abortion. Am J Obstet Gynecol 2002;187:393-7.
10. Owen J, Hauth JC. Vaginal misoprostol vs concentrated oxytocin plus low-dose prostaglandin E2 for second trimester pregnancy termination. J Matern Fetal Med 1999;8:48-50.
11. Bebbington MW, Kent N, Lim K, Gagnon A, Delisle MF, Tessier F, et al. A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination. Am J Obstet Gynecol 2002;187:853-7.
12. Kalish RB, Chasen ST, Rosenzweig LB, Rashbaum WK, Chervenak FA. Impact of midtrimester dilation and evacuation on subsequent pregnancy outcome. Am J Obstet Gynecol 2002;187:882-5.
13. Bussel JB, Zabusky MR, Berkowitz RL, McFarland JG. Fetal alloimmune thrombocytopenia. N Engl J Med 1997;337:22-6.